International Journal of Peptide Research and Therapeutics · 2021 · 15 citations · 69 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunoeditingCancer ImmunotherapyCheckpoint Inhibitor TherapyNeoantigen-based ImmunotherapyTumor AntigensTumor-associated AntigensImmunogenicity Of Tumor AntigensPeptide-based ImmunomodulationPeptide-based ImmunotherapyTumor-homing PeptidesTumor-targeting Peptides
69
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert, Jacob Schachter, Georgina V. Long et al. · New England Journal of Medicine · 2015 · 5.8K citations · Full text
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott, Zhuting Hu, Derin B. Keskin et al. · Nature · 2017 · 2.9K citations
Medicine, Immunology, Oncology +12
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Uğur Şahin, Evelyna Derhovanessian, Matthias Miller et al. · Nature · 2017 · 2.5K citations
Medicine, Immunology, Oncology +14
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon, Roy L. Maute, Ben W. Dulken et al. · Nature · 2017 · 2.3K citations · Full text
Life Sciences, Immunology, Oncology +16